Journal
BIOFACTORS
Volume 37, Issue 5, Pages 366-373Publisher
WILEY
DOI: 10.1002/biof.154
Keywords
coenzyme Q(10); hypertension; endothelial dysfunction; diabetes; antioxidants; ischemic heart disease; extracellular SOD
Ask authors/readers for more resources
Since the time a precise role of coenzyme Q(10) (CoQ(10)) in myocardial bioenergetics was established, the involvement of CoQ in the pathophysiology of heart failure was hypothesized. This provided the rationale for numerous clinical trials of CoQ(10) as adjunctive treatment for heart failure. A mild hypotensive effect of CoQ was reported in the early years of clinical use of this compound. We review early human and animal studies on the vascular effects of CoQ. We then focus on endothelial dysfunction in type 2 diabetes and the possible impact on this condition of antioxidants and nutritional supplements, and in particular the therapeutic effects of CoQ. The effect of CoQ(10) on endothelial dysfunction in ischemic heart disease is also reviewed together with recent data highlighting that treatment with CoQ(10) increases extracellular SOD activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available